Table 4.
DBV scheme of administration: lines correspond to number of DBV doses and time between administrations, columns refer to dosages administered (expressed in mg). (*) 1 patient was treated with 2000 mg + 500 mg × 4; (**) 1 patient was treated with 1500 mg + 1000 mg + 500 mg × 3; (***) 1 patient was treated with 1000 mg × 2; (****) 1 patient was treated with 1000 mg + 1000 mg + 500 mg × 6.
| DBV Scheme of Administration | n | 1500 + 1500 * n | 1500 + 1000 * n | 1500 + 500 * n | 1000 + 500 * n | 750 + 750 * n | Total (320 Patients) |
|---|---|---|---|---|---|---|---|
| 1 dose | 0 | 26 | 6 | 0 | 32 (10.0%) | ||
| 2 doses, More than 1 week apart |
1 | 9 | 3 | 1 | 0 | 0 | 13 (4.1%) |
| 2 doses, 1 week apart |
1 | 177 | 0 | 2 | 5 *** | 0 | 184 (57.5%) |
| 3 doses, More than 1 week apart |
2 | 7 | 0 | 0 | 1 | 0 | 8 (2.5%) |
| 3 doses, 1 week apart |
2 | 3 | 0 | 0 | 4 | 0 | 7 (2.2%) |
| 4 doses, More than 1 week apart |
3 | 10 | 17 | 0 | 3 | 0 | 30 (9.4%) |
| 4 doses, 1 week apart |
3 | 0 | 0 | 1 * | 4 | 0 | 5 (1.6%) |
| > 4 doses | x | 3 | 9 | 4 ** | 24 **** | 1 | 41 (12.8%) |